TAPIS: a positive trial in a defined phenotype

Key Points

• The aim is to assess the effectiveness of an intervention in patients with a specific defined phenotype.
• Conducted as a randomized clinical trial
• Focused on participants with a predefined phenotype
• Evaluated treatment response with defined biomarkers
• The intervention showed a significant improvement in treatment response (p<0.05)
• Increased biomarker levels were observed post-treatment
• Positive outcomes were prominently noted in the defined phenotype group